| Identification | Back Directory | [Name]
S-((9H-fluoren-9-yl)methyl)-N-((allyloxy)carbonyl)-L-cysteine | [CAS]
182201-77-0 | [Synonyms]
Alloc-Cys(Fm)-OH
N-[(Allyloxy)carbonyl]-S-(9H-fluoren-9-ylmethyl)-L-cysteine
S-((9H-fluoren-9-yl)methyl)-N-((allyloxy)carbonyl)-L-cystein
S-((9H-fluoren-9-yl)methyl)-N-((allyloxy)carbonyl)-L-cysteine
L-Cysteine,S-(9H-fluoren-9-ylmethyl)-N-[(2-propenyloxy)carbonyl]-
S-(9H-Fluoren-9-ylmethyl)-N-[(2-propen-1-yloxy)carbonyl]-L-cysteine
L-Cysteine, S-(9H-fluoren-9-ylmethyl)-N-[(2-propen-1-yloxy)carbonyl]-
(R)-3-(((9H-Fluoren-9-yl)methyl)thio)-2-(((allyloxy)carbonyl)amino)propanoic acid
(2R)-3-(9H-fluoren-9-ylmethylsulfanyl)-2-(prop-2-enoxycarbonylamino)propanoic acid
(2S)-3-{[(9H-fluoren-9-yl)methyl]sulfanyl}-2-{[(prop-2-en-1-yloxy)carbonyl]amino}propanoic acid | [Molecular Formula]
C21H21NO4S | [MDL Number]
MFCD30573902 | [MOL File]
182201-77-0.mol | [Molecular Weight]
383.46 |
| Chemical Properties | Back Directory | [Boiling point ]
607.4±55.0 °C(Predicted) | [density ]
1.272±0.06 g/cm3(Predicted) | [pka]
3.50±0.10(Predicted) | [InChI]
InChI=1S/C21H21NO4S/c1-2-11-26-21(25)22-19(20(23)24)13-27-12-18-16-9-5-3-7-14(16)15-8-4-6-10-17(15)18/h2-10,18-19H,1,11-13H2,(H,22,25)(H,23,24)/t19-/m0/s1 | [InChIKey]
MUSZBDPVJSUUQY-IBGZPJMESA-N | [SMILES]
C(O)(=O)[C@H](CSCC1C2=C(C=CC=C2)C2=C1C=CC=C2)NC(OCC=C)=O |
| Hazard Information | Back Directory | [Uses]
S-(9H-Fluoren-9-ylmethyl)-N-[(2-propen-1-yloxy)carbonyl]-L-cysteine is a useful reactant for the synthesis of Ecteinascidin 743, more commonly known as Trabectedin, an antitumor chemotherapy drug. |
|
| Company Name: |
Energy Chemical
|
| Telephone: |
400-0056266 |
| Website: |
www.energy-chemical.com |
| Company Name: |
Shanghai GL Peptide Ltd.
|
| Telephone: |
+86-21-61263310 13764994101 |
| Website: |
www.chemicalbook.com/supplier/10480342/ |
| Company Name: |
Henan Alfachem Co.,Ltd.
|
| Telephone: |
0371-55051623 18137891487 |
| Website: |
www.chemicalbook.com/supplier/14555231/ |
|